---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003829"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T15:56:27.424670+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals sets 2025 Annual Meeting for May 20; proposal deadline April 18

## Summary
- Annual Meeting will be held virtually on May 20, 2025 at 10:00 a.m. Eastern.
- Deadline for Rule 14a-8 stockholder proposals is April 18, 2025, close of business.
- Deadline for director nominations and universal proxy notices also April 18, 2025.
- Meeting date changed by more than 30 days from 2024 anniversary, triggering new deadlines.

## SEC filing metadata
- accession: 0001641172-25-003829
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000164117225003829/0001641172-25-003829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000164117225003829/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003829
- JSON: https://secwatch.observer/filing/0001641172-25-003829.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003829.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.